Breast Cancer Research

official impact factor 5.79

Open Access Highly Access Research article

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

Christos Markopoulos*, Urania Dafni, John Misitzis, Vasilios Zobolas, Evagelos Tzoracoleftherakis, Dimitrios Koukouras, Grigorios Xepapadakis, John Papadiamantis, Basileios Venizelos, Zoh Antonopoulou and Helen Gogas

Breast Cancer Research 2009, 11:R35 doi:10.1186/bcr2320

No comments have yet been made on this article.

Post a comment